Non-Hodgkin Lymphoma VA Disability Rating is rated by the U.S. Department of Veterans Affairs under DC 7715 of 38 C.F.R. § 4.117 across 3 severity tiers (40%+ -- Severe limitation or ankylosis / 20% -- Moderate limitation / 10% -- Mild limitation or painful motion). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.
Non-Hodgkin lymphoma (DC 7715) rates at 100% during active disease. Presumptive for Agent Orange/herbicide exposure under 38 C.F.R. 3.309(e). After treatment, rated on residuals with mandatory 6-month observation period before reduction.
Non-Hodgkin Lymphoma (DC 7715) is evaluated under 38 C.F.R. § 4.117 using the hematologic rating framework. Because it is rated by analogy to the general schedule, the 3 levels below describe the body-system criteria the VA applies — the percentage assigned to Non-Hodgkin Lymphoma depends on the specific findings (range of motion, frequency, severity, or functional loss) documented at the C&P exam and in the medical record.
Rating criteria reference 38 C.F.R. Part 4 (Schedule for Rating Disabilities). This entry has not yet undergone editorial review against the live regulation text — consult the authoritative source directly before relying on the criteria shown.